Kejin Zhou

Principal Scientist, Nanotechnology
Poseida Therapeutics
Sven Stegemann
Kejin Zhou received Ph.D. in Polymer Chemistry and Physics from The Shanghai Institute of Organic Chemistry of Chinese Academy of Sciences in 2009. To connect with translational cancer research, he came to the Simmons Comprehensive Cancer Center of UT Southwestern Medical Center, Dallas as Postdoc and then Instructor. He joined Poseida Therapeutics as Principal Scientist in January 2020. During the research journey from pure chemistry to nanomedicine, Dr. Zhou has been amazed by the way that the chemical characteristics of molecules dictates their self-assembly, nano-bio interface behaviors, chemical and physical properties, and bioactivities.

Sessions

No data was found